| EPB0120 | Can HIV low level viremia predict future anti-retroviral treatment failure? A retrospective cohort analysis from Zambia | E-poster | Diagnostic and monitoring tools |
| EPB0121 | The value of National Xpert MTB/RIF Ultra trace results in context of new molecular diagnostics: more questions than answers? | E-poster | Diagnostic and monitoring tools |
| EPB0122 | Concordance of self-reported and point-of-care biomarkers of alcohol use measures among older adults with HIV from low- and middle-income countries, the Sentinel Research Network of IeDEA | E-poster | Diagnostic and monitoring tools |
| EPB0123 | Improving the diagnosis of HIV in hospitalized infants: lessons learned from the EMPIRICAL trial | E-poster | Diagnostic and monitoring tools |
| EPB0124 | Severe mpox (monkeypox) among people living with HIV in Peru: a clinical case series of hospitalized cases, 2022 | E-poster | Diagnostic and monitoring tools |
| EPB0125 | Factors associated with non-viral load suppression in Togo | E-poster | Diagnostic and monitoring tools |
| EPB0126 | Establishing a CrAg referral testing program to expand screening for Cryptococcal Meningitis in Lesotho | E-poster | Diagnostic and monitoring tools |
| EPB0127 | Effects of direct-acting antiviral therapy on immunologic and hepatic markers among people with HIV/HCV coinfections | E-poster | Co-infections (including opportunistic infections) |
| EPB0128 | Implementation of HCV treatments among people living with HIV/HCV in Washington, DC | E-poster | Co-infections (including opportunistic infections) |
| EPB0129 | Role of low-risk HPV PCR in screening for HSIL lesions and anal cancer in men who have sex with men (MSM) living with HIV (MSM-LWHIV) | E-poster | Co-infections (including opportunistic infections) |